Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases

Molecules. 2021 Dec 22;27(1):56. doi: 10.3390/molecules27010056.

Abstract

Inhibition of bacterial virulence is believed to be a new treatment option for bacterial infections. In the present study, we tested dipicolylamine (DPA), tripicolylamine (TPA), tris pyridine ethylene diamine (TPED), pyridine and thiophene derivatives as putative inhibitors of the bacterial virulence factors thermolysin (TLN), pseudolysin (PLN) and aureolysin (ALN) and the human zinc metalloproteases, matrix metalloprotease-9 (MMP-9) and matrix metalloprotease-14 (MMP-14). These compounds have nitrogen or sulfur as putative donor atoms for zinc chelation. In general, the compounds showed stronger inhibition of MMP-14 and PLN than of the other enzymes, with Ki values in the lower μM range. Except for DPA, none of the compounds showed significantly stronger inhibition of the virulence factors than of the human zinc metalloproteases. TPA and Zn230 were the only compounds that inhibited all five zinc metalloproteinases with a Ki value in the lower μM range. The thiophene compounds gave weak or no inhibition. Docking indicated that some of the compounds coordinated zinc by one oxygen atom from a hydroxyl or carbonyl group, or by oxygen atoms both from a hydroxyl group and a carbonyl group, and not by pyridine nitrogen as in DPA and TPA.

Keywords: bacterial virulence factors; docking; enzyme inhibition; matrix metalloproteases; molecular interactions; zinc chelators.

MeSH terms

  • Amino Acids
  • Bacteria / drug effects
  • Bacteria / enzymology
  • Catalytic Domain
  • Chelating Agents / chemistry*
  • Chelating Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Humans
  • Metalloproteases / antagonists & inhibitors*
  • Metalloproteases / chemistry*
  • Models, Molecular
  • Molecular Conformation
  • Molecular Structure
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / pharmacology*
  • Structure-Activity Relationship
  • Zinc Compounds / chemistry*
  • Zinc Compounds / pharmacology*

Substances

  • Amino Acids
  • Chelating Agents
  • Protease Inhibitors
  • Zinc Compounds
  • Metalloproteases